Dr Kumitaa Theva Das
Dr. Kumitaa Theva Das is a Senior Lecturer at the Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia (USM). She is a prominent geneticist who earned her BSc in Biotechnology and PhD in Genetics from the University of California, Davis, training in one of the pioneer laboratories for genome editing in the United States. With over 15 years of experience in genome editing, her research focuses on developing CRISPR/Cas9 technology as a therapeutic tool for infectious diseases, particularly HIV/AIDS, and cancer. Dr. Kumitaa is a recognized expert in her field, serving on the United Nations’ expert group on genome editing and as a co-chair for a sub-committee of Malaysia’s Genetic Modification Advisory Committee. Beyond the lab, she is an active science communicator and TEDx speaker, passionate about the ethical application of precision medicine.
(2025-2026)
- Suleiman et al. (2026) Design, Synthesis, ADMET Profiling, POM Analysis and Molecular Dynamics Studies of Coumarin-DAPY Derivatives as HIV-1 Reverse Transcriptase Inhibitors, Journal of Molecular Structure, 145278
- Zulkifli et al. (2026) CRISPR/Cas9: the future of human gene editing, DNA in Health, Identity, and Ancestry, 53-82
- Kalidasan et al. (2025) Learning from nature: HIV elite controllers as blueprints for a functional cure, Virology Journal, 23, 23
-
Suleiman et al. (2025) Vanillin Derivatives in Drug Design: Structure–Activity Relationship (SAR) Hotspots and Synthetic Pathways for Enhanced Pharmacological Activity, ACS omega 10 (48), 57846-57875
-
Theva Das (2025) From bench to bedside: the future of stable lentiviral packaging cell lines in gene therapy, Gene Therapy 32 (5), 569-571
2026 -
TFM522